Diazoxide in treatment of primary pulmonary hypertension.
作者信息
Rubino J M, Schroeder J S
出版信息
Br Heart J. 1979 Sep;42(3):362-3. doi: 10.1136/hrt.42.3.362.
Abstract
摘要
相似文献
1
Diazoxide in treatment of primary pulmonary hypertension.二氮嗪治疗原发性肺动脉高压
Br Heart J. 1979 Sep;42(3):362-3. doi: 10.1136/hrt.42.3.362.
2
Diazoxide in primary pulmonary hypertension.二氮嗪用于原发性肺动脉高压
N Engl J Med. 1980 Jan 10;302(2):91-2. doi: 10.1056/NEJM198001103020204.
3
Diazoxide in treatment of primary pulmonary hypertension.二氮嗪治疗原发性肺动脉高压
Br Heart J. 1978 May;40(5):572-4. doi: 10.1136/hrt.40.5.572.
4
Vasodilator therapy for pulmonary hypertension.肺动脉高压的血管扩张剂治疗
N Engl J Med. 1980 May 29;302(22):1260. doi: 10.1056/NEJM198005293022213.
5
Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.口服二氮嗪治疗六年期间原发性肺动脉高压的可逆性
Br Heart J. 1987 Feb;57(2):207-9. doi: 10.1136/hrt.57.2.207.
6
Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.二氮嗪在原发性肺动脉高压中的临床及血流动力学效应
Thorax. 1980 Apr;35(4):269-76. doi: 10.1136/thx.35.4.269.
7
Hazards of diazoxide in pulmonary hypertension.二氮嗪在肺动脉高压中的危害。
Br Heart J. 1981 Oct;46(4):401-3. doi: 10.1136/hrt.46.4.401.
8
9
[Primary pulmonary hypertension: current therapeutic prospectives].[原发性肺动脉高压：当前的治疗前景]
Cardiologia. 1982 Sep;27(9):883-94.
10
[Primary pulmonary arterial hypertension. Trial treatment with nifedipine, diazoxide and isoproterenol].[原发性肺动脉高压。硝苯地平、二氮嗪和异丙肾上腺素的试验性治疗]
Nouv Presse Med. 1980 Dec 20;9(48):3698-9.
引用本文的文献
1
Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.特发性肺动脉高压中的血管扩张剂反应性：识别具有不同生理特征和不同预后的独特表型。
Pulm Circ. 2017 Jul-Sep;7(3):588-597. doi: 10.1177/2045893217714231. Epub 2017 Jun 20.
2
Detrimental effects of verapamil in patients with primary pulmonary hypertension.维拉帕米对原发性肺动脉高压患者的有害影响。
Br Heart J. 1984 Jul;52(1):106-11. doi: 10.1136/hrt.52.1.106.
3
Management of primary pulmonary hypertension.原发性肺动脉高压的管理
Br Heart J. 1985 Jan;53(1):1-4. doi: 10.1136/hrt.53.1.1.
4
Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.口服二氮嗪治疗六年期间原发性肺动脉高压的可逆性
Br Heart J. 1987 Feb;57(2):207-9. doi: 10.1136/hrt.57.2.207.
5
Primary pulmonary hypertension.原发性肺动脉高压
Br Med J (Clin Res Ed). 1986 Dec 6;293(6560):1456-7. doi: 10.1136/bmj.293.6560.1456.
6
Drug treatment of primary pulmonary hypertension.
Drugs. 1986 Feb;31(2):177-84. doi: 10.2165/00003495-198631020-00006.
本文引用的文献
1
[Effect of diazoxide, a new bllood pressure lowering substance, on the general and pulmonary circulatory system in hypertension].[新型降压物质二氮嗪对高血压患者全身及肺循环系统的作用]
Z Kreislaufforsch. 1969 Sep;58(9):925-36.
2
3
Influence of intravenous injection rate on protein binding and vascular activity of diazoxide.静脉注射速率对二氮嗪蛋白结合及血管活性的影响。
Ann N Y Acad Sci. 1973 Nov 26;226:319-32. doi: 10.1111/j.1749-6632.1973.tb20493.x.
Zotero 插件